IRCT2015071323184N1CompletedPhase 2
The effect of atorvastatin on the disease process in patients with multiple sclerosis
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Enrollment
- 60
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 1 year to no limit (—)
- Sex
- All
Inclusion Criteria
- •Informed consent for entering the study and Fill out the form informed consent; MS disease
- •Exclusion criteria: Side effects of the drug
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Completed
Phase 2
Atorvastatin effect on ulcerative colitisIRCT20210713051878N1Islamic Azad University40
Recruiting
Phase 2
?The effect of Atorvastatin therapy in COVID-19IRCT20190831044653N5Bojnourd University of Medical Sciences160
Recruiting
Phase 3
The effect of atorvastatin in the prevention of gastrointestinal toxicity in patients undergoing pelvic radiotherapyIRCT20200825048515N36Esfahan University of Medical Sciences64
Recruiting
Phase 3
The effect of atorvastatin administration on the outcome of patients with traumatic brain injuryIRCT20210113050023N1Ahvaz University of Medical Sciences60
Not yet recruiting
Phase 3
The effect of atorvastatin on Covid 19IRCT20210426051090N1Shahre-kord University of Medical Sciences80